Showing 15,241 - 15,260 results of 17,628 for search '"progress"', query time: 0.10s Refine Results
  1. 15241

    Oscillometry reference values for children and adolescents by Christoph Valach, Emiel F. M. Wouters, Alina Ofenheimer, Pasquale Pio Pompilio, Alessandro Gobbi, Marie-Kathrin Breyer, Sylvia Hartl, Chiara Veneroni, Tobias Mraz, Caspar Schiffers, Otto Chris Burghuber, Ahmad Karimi, Christoph Gross, Charles Irvin, Robab Breyer-Kohansal

    Published 2024-12-01
    “…Results Reference equations for all oscillometry parameters were created for Caucasian children aged 6 to 17 years with a height span from 101 to 183 cm and a lung volume span from 1.7 to 8.8 L TLC. R and Z values progressively decrease and X values increase with increasing height. …”
    Get full text
    Article
  2. 15242

    AdipoR1 enhances the radiation resistance via ESR1/CCNB1IP1/cyclin B1 pathway in hepatocellular carcinoma cells by Yuhan Gan, Linhui Zhu, Yimo Li, Ruoting Ge, Jiahe Tian, Yuxin Chen, Xiang He, Shumei Ma, Xiaodong Liu

    Published 2025-01-01
    “…We found that AdipoR1 promoted the translocation of ESR1 from the cytoplasm to the nucleus, and ESR1 inhibited the transcription of CCNB1IP1.Therefore, we propose that AdipoR1 regulates the ubiquitination level, cell cycle progression, and radiation resistance of HCC cells through the “AdipoR1 /ESR1/CCNB1IP1/cyclin B1” axis. …”
    Get full text
    Article
  3. 15243

    DeepGlioSeg: advanced glioma MRI data segmentation with integrated local-global representation architecture by Ruipeng Li, Yuehui Liao, Yueqi Huang, Xiaofei Ma, Guohua Zhao, Yanbin Wang, Chen Song

    Published 2025-02-01
    “…IntroductionGlioma segmentation is vital for diagnostic decision-making, monitoring disease progression, and surgical planning. However, this task is hindered by substantial heterogeneity within gliomas and imbalanced region distributions, posing challenges to existing segmentation methods.MethodsTo address these challenges, we propose the DeepGlioSeg network, a U-shaped architecture with skip connections for continuous contextual feature integration. …”
    Get full text
    Article
  4. 15244

    Bioelectronic osteosynthesis plate to monitor the fracture bone healing using electric capacitive variations by Diogo G. Pires, Nuno M. Silva, A. Completo, Marco P. Soares dos Santos

    Published 2025-01-01
    “…Methods An innovative bioelectronic osteosynthesis plate, minimally customized from a fixation device used in clinical practice, was developed to monitor the bone-implant interface to effectively detect the progression of bone fractures stages. Our technology includes a network-architectured capacitive interdigitated system, a Bluetooth module, an analog-to-digital converter, a multiplexer, a microcontroller, and a miniaturized battery. …”
    Get full text
    Article
  5. 15245

    Global burden of colorectal cancer: epidemiology, risk factors by E. A. Medvedeva, G. G. Maryin, A. A. Leshchenko, M. V. Chernogorova, M. B. Dolgova, D. A. Nazarov, S. A. Ivanov

    Published 2022-12-01
    “…The practitioner needs to be aware of the risk factors leading to CRC and the various stages of disease progression in order to recommend appropriate screening strategies. …”
    Get full text
    Article
  6. 15246

    Scapholunate advanced collapse of the wrist: a review by Nathalia A. Shchudlo, Shyngys K. Kuttygul, Artem R. Mironov

    Published 2024-12-01
    “…It is characterized by progressive deformity, instability and arthritis due to chronic dissociation of the scaphoid and lunate bones with chronic scapholunate interosseous ligament (SLIL) injuries. …”
    Get full text
    Article
  7. 15247

    Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients by Mélanie Saint-Jean, Anne-Chantal Knol, Christelle Volteau, Gaëlle Quéreux, Lucie Peuvrel, Anabelle Brocard, Marie-Christine Pandolfino, Soraya Saiagh, Jean-Michel Nguyen, Christophe Bedane, Nicole Basset-Seguin, Amir Khammari, Brigitte Dréno

    Published 2018-01-01
    “…Therapeutic responses included a complete remission, a partial remission, 2 stabilizations, and 6 progressions. Among these 4 patients with clinical benefit, 1 is still alive with 9 years of follow-up and 1 died from another cause after 8 years of follow-up. …”
    Get full text
    Article
  8. 15248

    An Intriguing Case of Multisystem Inflammatory Syndrome in an Adult Patient with Remote Infection with COVID-19 and Acute Chlamydia by Madhuri Chandnani, William A. Charini, Anil Jha, Chetan Dodhia, Eduardo Haddad

    Published 2021-01-01
    “…A 27-year-old male patient presented with acute epididymitis secondary to acute Chlamydia infection that progressed to multisystem inflammatory failure with respiratory failure requiring endotracheal intubation and mechanical ventilation, cardiogenic shock with heart failure, and gastrointestinal and renal dysfunction. …”
    Get full text
    Article
  9. 15249

    Economic consequences of the phenomenon of uberization on the example of the services of selected carriers in the transport industry by Nina Stępnicka, Grygorii Monastyrskyi, Beata Sadowska, Robert Walasek, Paulina Wiączek, Grzegorz Zimon

    Published 2025-01-01
    “…The purpose of the study was to determine the impact of the progressive phenomenon of uberization on the competitiveness of the transportation industry in the pre-pandemic period and in the post-pandemic period. …”
    Get full text
    Article
  10. 15250

    The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer by Yi Zhao, Hengheng Zhang, Wenwen Wang, Guoshuang Shen, Miaozhou Wang, Zhen Liu, Jiuda Zhao, Jinming Li

    Published 2025-01-01
    “…Abstract The occurrence and progression of breast cancer (BCa) are complex processes involving multiple factors and multiple steps. …”
    Get full text
    Article
  11. 15251

    Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington’s Disease by Cristine de Paula Nascimento-Castro, Ana Claudia Wink, Victor Silva da Fônseca, Claudia Daniele Bianco, Elisa C. Winkelmann-Duarte, Marcelo Farina, Ana Lúcia S. Rodrigues, Joana Gil-Mohapel, Andreza Fabro de Bem, Patricia S. Brocardo

    Published 2018-01-01
    “…This study investigated whether chronic administration of the antioxidant probucol improved motor and affective symptoms as well as hippocampal neurogenic function in the YAC128 transgenic mouse model of HD during the early- to mild-symptomatic stages of disease progression. The motor performance and affective symptoms were monitored using well-validated behavioral tests in YAC128 mice and age-matched wild-type littermates at 2, 4, and 6 months of age, after 1, 3, or 5 months of treatment with probucol (30 mg/kg/day via water supplementation, starting on postnatal day 30). …”
    Get full text
    Article
  12. 15252

    Coculture with Eastern oysters is unlikely to reduce OsHV-1 impacts to farmed Pacific oysters: A modelling approach by Familusi Oluwatosin Adekunle, Gorka Bidegain, Tal Ben-Horin

    Published 2025-03-01
    “…Simulation results indicated that introducing C. virginica did not impede OsHV-1 progression; even in the M. gigas/C. virginica 10/90 system, M. gigas mortality reached its maximum, albeit delayed by approximately 10 days. …”
    Get full text
    Article
  13. 15253

    Soybean and avocado unsaponifiables: a review of their potential use in the treatment of osteoarthritis by Ana Sabucedo-Suárez, Ana Sabucedo-Suárez, Mónica López-Peña, Mónica López-Peña, María Permuy, María Permuy, Fernando Muñóz, Fernando Muñóz

    Published 2025-01-01
    “…Despite some discrepancies regarding structural changes in the joints, clinical trials typically demonstrate symptom relief and slow down the disease progression. While ASU demonstrates significant promise in alleviating OA symptoms and reducing reliance on NSAIDs, further research is essential to fully understand its mechanisms of action. …”
    Get full text
    Article
  14. 15254

    Cardiovascular Disease Detection through Innovative Imbalanced Learning and AUC Optimization by Karthikeyan Palanisamy, Krishnaveni Krishnasamy, Praba Venkadasamy

    Published 2024-03-01
    “…This similarity means it inherits PSVM's benefits, particularly in addressing progressive CVD scenarios with rapid incremental updates. …”
    Get full text
    Article
  15. 15255

    Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma by Ibrahim Büdeyri, Olaf Guckelberger, Elsie Oppermann, Dhruvajyoti Roy, Svenja Sliwinski, Felix Becker, Benjamin Struecker, Thomas J. Vogl, Andreas Pascher, Wolf O. Bechstein, Anna Lorentzen, Mathias Heikenwalder, Mazen A. Juratli

    Published 2024-12-01
    “…Circulating tumor cells (CTCs) expressing the dynamic polarity of the cytoskeletal membrane protein, ezrin, have been proposed to play a crucial role in tumor progression and metastasis. This study investigated the diagnostic and prognostic potential of polarized circulating tumor cells (p-CTCs) in HCC patients. …”
    Get full text
    Article
  16. 15256

    Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial by Pavlos Msaouel, Kai Yu, Ying Yuan, Jianfeng Chen, Xinmiao Yan, Menuka Karki, Fei Duan, Rahul A. Sheth, Priya Rao, Kanishka Sircar, Amishi Y. Shah, Amado J. Zurita, Giannicola Genovese, Min Li, Chih-Chen Yeh, Minghao Dang, Guangchun Han, Yanshuo Chu, Max Hallin, Peter Olson, Rui Yang, Daniela Slavin, Hirak Der-Torossian, Curtis D. Chin, Nizar M. Tannir, Linghua Wang, Jianjun Gao

    Published 2025-01-01
    “…Secondary endpoints were objective response rate (ORR), disease control rate (DCR), duration of response (DOR), progression-free survival (PFS), overall survival (OS), 1-year survival probability, and sitravatinib pharmacokinetics. …”
    Get full text
    Article
  17. 15257

    Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia by Tong-Yoon Kim, Gi-June Min, Young-Woo Jeon, Seung-Ah Yahng, Seok-Goo Cho, Jong-Mi Lee, Myungshin Kim, Ki-Seong Eom

    Published 2025-01-01
    “…<b>Results</b>: The 5-year overall survival (OS) and 5-year progression-free survival (PFS) for all patients were 84.4% and 68.3%, respectively. …”
    Get full text
    Article
  18. 15258

    Outcomes of Surgical Treatment for Localized Tenosynovial Giant-Cell Tumor of the Foot and Ankle: A Case Series by Edoardo Ipponi, Alfio Damiano Ruinato, Leonardo Lombardi, Martina Cordoni, Silvia De Franco, Antonio D'Arienzo, Lorenzo Andreani

    Published 2023-10-01
    “…Localized lesions in this area are often manifested as firm masses or nodules with slow but continuous progression through months and years. Pain associated with weight-bearing, as well as limitations in joint motions, may be reported, depending on tumor’s location. …”
    Get full text
    Article
  19. 15259

    Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model by Sofia Mickaela Martinez, Ayelen Inda, Maximiliano Nicolás Ríos, Carolina del Valle Bessone, Abril Bruera Bossio, Mario Eduardo Guido, José Domingo Luna Pinto, Daniel Alberto Allemandi, Daniela Alejandra Quinteros

    Published 2025-01-01
    “…Oxidative stress plays a key role in their development, damaging retinal cells and accelerating disease progression. Melatonin (Mel) is a potent antioxidant with neuroprotective properties; however, it faces limitations such as low solubility. …”
    Get full text
    Article
  20. 15260

    Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence by Yuta Yamanaka, Yukiko Okuno, Keisuke Kamisako, Yuta Okazaki, Kentaro Nakanishi, Yume Sanada, Kiyori Yoshida, Tatsuki Ikoma, Yuki Takeyasu, Utae Katsushima, Hiroshige Yoshioka, Takayasu Kurata

    Published 2024-12-01
    “…We assessed the efficacy of the two ICIs across various factors. Results The progression‐free survival (PFS) and overall survival (OS) did not significantly differ between Atezo + CE and Durva + CE/PE as first‐line chemotherapy treatments for SCLC. …”
    Get full text
    Article